The Department of Justice Drug Enforcement Administration awarded a firm fixed price purchase order valued at $48,560.76 to Agilent Technologies Inc., Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc. Agilent Technologies Headquarters Division. The contract is for the delivery of a highly specialized liquid chromatography-mass spectrometry instrument, which is the only instrument of its kind suited for low-level substance analysis in the laboratory located in Marshallton, Delaware. The period of performance is July 1, 2023 through June 30, 2024. As the Drug Enforcement Administration's mission involves enforcement of controlled substances laws and regulations, this analytical technology will support identification of unknown samples as part of the agency's regulatory compliance and criminal investigations efforts.
Generated 12/18/23, 4:14 PM